drugset / Trial / NCT01245322
Treatment of Bacterial Vaginosis Combined With Human Lactobacilli
NaSingle-groupOpen-labelTreatment
Summary
The primary objectives of this study were to characterize lactobacilli of human vaginal origin and to investigate if more extended antibiotic treatment against Bacterial Vaginosis, together with adjuvant lactobacilli treatment, could increase the cure rate and furthermore, to investigate factors that could influence relapse.
Timeline
- Start
- 2007-01
- Primary completion
- 2014-10
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clindamycin | Unknown | 2 % | Other |
| Comparator | Clindamycin | Unknown | 300 mg | Other |
| Comparator | lactobacilli | Unknown | 1e+09 cells | Other |